NCT04297592View on ClinicalTrials.gov

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

4,618

Participants

Timeline

Start Date

June 11, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Infections Joint ProstheticOverweight or ObesityMSSA ColonizationMRSAChronic Kidney DiseasesDiabetesAutoimmune DiseasesInflammatory DiseaseTobacco Use
Interventions
DRUG

Cephalexin

500 mg oral tablet, 4 times daily for 7 days

DRUG

Doxycycline

100 mg oral tablet, 2 times daily for 7 days

DRUG

Cefadroxil

500 mg oral tablet, 2 times daily for 7 days

Trial Locations (2)

52242

University of Iowa Hospitals & Clinics, Iowa City

55902

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04297592 - Antibiotic Prophylaxis in High-Risk Arthroplasty Patients | Biotech Hunter | Biotech Hunter